|
시장보고서
상품코드
2088984
기존 상처 관리 시장 : 제품 유형, 창상 유형, 소재 유형, 제품 사용성, 유통 채널, 최종 사용자별 예측(2026-2032년)Traditional Wound Care Market by Product Type, Wound Type, Material Type, Product Usability, Distribution Channel, End User - Global Forecast 2026-2032 |
||||||
360iResearch
기존 상처 관리 시장은 2032년까지 연평균 복합 성장률(CAGR) 5.29%로 105억 6,000만 달러 규모로 확대될 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도 : 2025년 | 73억 6,000만 달러 |
| 추정 연도 : 2026년 | 77억 4,000만 달러 |
| 예측 연도 : 2032년 | 105억 6,000만 달러 |
| CAGR(%) | 5.29% |
기존 상처 관리 시장의 도입
기존 상처 관리 시장은 여전히 전 세계 상처 관리의 중요한 기반을 이루고 있으며, 병원, 외래수술센터(ASC), 장기 요양 시설, 소매 약국, 응급 처치, 재택치료 등에서 사용되는 거즈 드레싱, 붕대, 의료용 테이프, 면 제품, 스펀지 및 기본적인 흡수성 드레싱을 포괄합니다. 이러한 제품들은 비용 대비 효과가 뛰어나고, 널리 구할 수 있으며, 임상의들에게도 친숙할 뿐만 아니라, 수술 상처, 외상, 화상, 욕창 및 일상적인 드레싱 교체 관리에 필수적이기 때문에 앞으로도 꾸준한 수요가 예상됩니다.
기존 상처 관리에 가져온 혁신적인 변화
업계 동향은 수량 위주의 범용 제품 공급에서 임상적 신뢰성이 높고 조달 효율이 뛰어나며 규정 준수 체계가 잘 갖춰진 상처 관리 제품군으로 전환되고 있습니다. 의료 시스템에서는 처방집의 표준화가 추진되고, 재고 관리 단위(SKU)를 줄이는 한편, 간호 시간 단축, 오염 위험 감소, 그리고 치료 기간 전체의 총비용 절감으로 이어지는 제품이 우선적으로 채택되고 있습니다. 이러한 추세는 기존 드레싱에 일관된 품질, 무균 포장, 추적 가능성, 그리고 병원과의 강력한 계약 체결 능력을 결합할 수 있는 제조업체에게 새로운 기회를 창출하고 있습니다.
상처 관리 분야에서 AI가 미치는 누적 영향
인공지능(AI)은 기존 상처 관리 제품을 대체하는 것은 아니지만, 이러한 제품의 선정, 재고 관리, 사용 방법을 변화시키고 있습니다. AI를 활용한 상처 영상 진단, 위험도 분류 및 디지털 기록을 통해 임상의는 상처의 진행 상황을 파악하고, 감염 위험을 특정하며, 기본적인 거즈나 붕대로 대응할 수 있는 경우와 고도의 드레싱이나 전문의의 개입이 필요한 경우를 정확히 판단할 수 있습니다. 이를 통해 제품의 활용 효율이 향상되고, 근거에 기반한 상처 관리 과정이 지원됩니다.
기존 상처 관리에 관한 주요 지역별 인사이트
아시아태평양은 중국, 인도, 일본, 한국, 호주 및 아세안(ASEAN) 시장에서 수술 능력 확대, 당뇨병 유병률 증가, 급속한 도시화, 그리고 병원 및 외래 진료 서비스에 대한 접근성 확대가 진행되고 있어, 기존 상처 치료 분야에서 높은 성장이 예상되는 시장으로 부상하고 있습니다. 또한, 이 지역은 의료용 섬유 분야의 강력한 생산 능력을 강점으로 삼고 있으며, 거즈, 붕대, 면 롤, 흡수성 상처 관리 제품의 주요 생산 거점으로 자리 잡고 있습니다. 한편, 일본, 한국, 중국, 호주에서 고령화가 진행됨에 따라 일상적인 상처 관리 및 수술 후 드레싱에 대한 수요가 더욱 증가하고 있습니다.
세계 각국의 제휴와 관련된 주요 그룹에 대한 인사이트
아세안 지역 수요는 인도네시아, 태국, 베트남, 말레이시아, 필리핀 등 시장에서 의료보험 적용 범위 확대, 의료 관광, 도시 지역 병원 투자, 그리고 1차 진료 접근성 개선에 힘입어 뒷받침되고 있습니다. 기존 상처 관리 제품은 수술 후 회복, 응급 의료, 산재 관리, 지역 의료 현장 등에서 널리 활용되고 있다는 장점이 있지만, 가격에 대한 민감성 때문에 신뢰성이 높고 비용이 저렴하며 안정적인 공급이 보장되는 제품 형태가 계속해서 선호되고 있습니다.
기존 상처 관리 분야에서 주요 국가들의 동향
미국은 수술 건수가 많고, 외래 진료가 광범위하며, 응급 의료 이용이 활발하고, 재택치료가 널리 보급되어 있을 뿐만 아니라 확립된 병원 조달 네트워크를 갖추고 있어, 기존 상처 관리 분야에서 가장 큰 전략적 시장으로 자리매김하고 있습니다. 캐나다에서는 품질, 보험 급여 규정, 지역 의료 시스템의 조달, 도시와 외딴 지역의 의료 현장에서의 공평한 접근성이 중시되고 있습니다. 한편, 멕시코는 민간 의료의 확대, 공립 병원 수요, 의료 관광, 그리고 북미 공급망과의 근접성 등의 요인으로 인해 혜택을 보고 있습니다. 브라질은 대규모 병원 네트워크, 공공 의료 서비스 이용, 외상 치료 수요, 그리고 만성 질환의 큰 부담에 힘입어 라틴아메리카의 주요 시장입니다.
업계 리더를 위한 실천적인 제안
업계 선두 기업은 멸균 거즈, 컨포밍 붕대, 접착 테이프, 드레싱 팩, 면 롤, 복부용 패드, 수술용 스폰지 등 수요가 높은 주요 카테고리를 중심으로 제품 포트폴리오를 강화하는 한편, 멸균 보증, 포장 편의성, 피부 친화적인 접착제, 흡수성 안정성, 명확한 표시, 공급 신뢰성을 통해 차별화를 꾀해야 합니다. 가격만으로 경쟁하면 이익률에 대한 압박이 커지지만, 종합적인 가치, 문서화, 임상에서의 사용 편의성, 그리고 안정적인 공급 체계를 바탕으로 경쟁함으로써 구매자의 재구매율을 높일 수 있습니다.
조사 방법
본 요약 보고서는 2차 조사, 시장 삼각측량 및 검증된 의료 지표에 대한 정성적 해석을 바탕으로 작성되었습니다. 본 분석에서는 전 세계 질병 부담에 관한 증거, 당뇨병 유병률 지표, 외과 의료 동향, 인구 고령화 통계, 외상 및 교통사고로 인한 부상 데이터, 의료 접근성 지표, 의료 인프라 구축 현황 등 공인 기관이 제공한 공중보건 데이터를 고려하고 있습니다.
결론
기본적인 드레싱, 거즈, 붕대, 테이프, 면 제품, 스펀지는 거의 모든 의료 현장에서 사용되고 있기 때문에 기존 상처 관리 방법은 여전히 전 세계 의료 분야에서 필수적인 요소입니다. 첨단 상처 관리 기술이 지속적으로 발전하는 한편, 기존 제품들은 합리적인 가격, 접근성, 임상 현장에서 익숙해진 사용 편의성, 보관의 용이성, 그리고 일상적인 상처 세척, 보호, 드레싱 교체와의 호환성을 통해 여전히 확고한 중요성을 유지하고 있습니다.
자주 묻는 질문
목차
제1장 서문
제2장 조사 방법
제3장 주요 요약
제4장 시장 개요
제5장 시장 인사이트
제6장 AI의 누적 영향, 2026년
제7장 기존 상처 관리 시장 : 제품 유형별
제8장 기존 상처 관리 시장 : 상처 유형별
제9장 기존 상처 관리 시장 : 소재 유형별
제10장 기존 상처 관리 시장 : 제품 사용성별
제11장 기존 상처 관리 시장 : 유통 채널별
제12장 기존 상처 관리 시장 : 최종 사용자별
제13장 기존 상처 관리 시장 : 지역별
제14장 기존 상처 관리 시장 : 그룹별
제15장 기존 상처 관리 시장 : 국가별
제16장 경쟁 구도
제17장 기업 개요
JHS 26.07.22The Traditional Wound Care Market is projected to grow by USD 10.56 billion at a CAGR of 5.29% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 7.36 billion |
| Estimated Year [2026] | USD 7.74 billion |
| Forecast Year [2032] | USD 10.56 billion |
| CAGR (%) | 5.29% |
Traditional Wound Care Market Introduction
The traditional wound care market remains a critical foundation of global wound management, covering gauze dressings, bandages, medical tapes, cotton products, sponges, and basic absorbent dressings used across hospitals, ambulatory surgical centers, long-term care, retail pharmacies, emergency response, and home healthcare. These products continue to see resilient demand because they are cost-effective, widely available, familiar to clinicians, and essential for managing surgical wounds, traumatic injuries, burns, pressure injuries, and routine dressing changes.
Demand is supported by well-documented public health trends, including population aging, the global rise in diabetes, higher surgical procedure volumes, and the ongoing burden of road traffic injuries and occupational trauma. Traditional wound care products are also indispensable in emergency preparedness, primary care, humanitarian response, and low-resource settings where affordability, distribution reach, sterility, and ease of use often determine access to basic wound treatment.
Transformative Shifts in Traditional Wound Care
The landscape is shifting from volume-led commodity supply toward clinically reliable, procurement-efficient, and compliance-ready wound care portfolios. Healthcare systems are standardizing formularies, seeking fewer stock-keeping units, and prioritizing products that reduce nursing time, contamination risk, and total episode-of-care cost. This trend is creating opportunities for manufacturers that can combine traditional dressings with consistent quality, sterile packaging, traceability, and strong hospital contracting capabilities.
Another important shift is the movement of care from hospitals to outpatient and home settings. As more post-surgical and chronic wound dressing changes occur outside acute-care facilities, demand is growing for user-friendly gauze, cohesive bandages, tapes, and dressing kits that support caregiver use, patient adherence, and safe disposal. Sustainability expectations are also increasing, with providers evaluating packaging reduction, responsible sourcing, latex-free materials, and supply chain resilience alongside price.
Cumulative Impact of AI on Wound Care
Artificial intelligence is not replacing traditional wound care products, but it is changing how they are selected, stocked, and used. AI-enabled wound imaging, risk stratification, and digital documentation can help clinicians identify wound progression, flag infection risk, and determine when basic gauze or bandage solutions are sufficient versus when advanced dressings or specialist intervention are needed. This improves product utilization and supports evidence-based wound care pathways.
AI is also influencing supply chain and commercial strategy. Predictive analytics can forecast demand for surgical dressings, compression bandages, and sterile gauze based on procedure schedules, seasonal injury patterns, trauma admissions, and chronic disease caseloads. For manufacturers and distributors, AI-driven inventory management can reduce stockouts, limit expired inventory, improve lot traceability, and strengthen service levels for hospitals, retail pharmacies, and home healthcare channels.
Key Regional Insights for Traditional Wound Care
Asia-Pacific is a high-growth environment for traditional wound care because of expanding surgical capacity, rising diabetes prevalence, rapid urbanization, and broader access to hospital and outpatient services in China, India, Japan, South Korea, Australia, and ASEAN markets. The region also benefits from strong medical textile manufacturing capabilities, making it a key production base for gauze, bandages, cotton rolls, and absorbent wound care products, while aging populations in Japan, South Korea, China, and Australia reinforce demand for routine wound management and post-operative dressings.
North America remains a mature but innovation-sensitive market, with the United States and Canada emphasizing infection prevention, reimbursement discipline, outpatient surgery, home health adoption, and standardized clinical protocols. Europe is shaped by universal healthcare systems, tender-based procurement, strict quality and regulatory expectations, and rising attention to sustainable healthcare purchasing. Latin America shows steady demand through public hospitals, private clinics, trauma care, and retail pharmacy channels in Brazil, Mexico, and other major economies, where affordability and distribution coverage remain central to supplier selection.
The Middle East is investing in hospital infrastructure, trauma care, emergency medicine, and surgical capacity, particularly across GCC countries, which supports demand for sterile dressings, surgical sponges, adhesive tapes, and bandage systems. Africa presents a needs-driven market where basic wound care access, affordability, donor-supported healthcare programs, community health networks, and local distribution capacity are decisive factors for adoption, especially in primary care, maternal health, trauma response, and infection prevention settings.
Key Group Insights Across Global Alliances
ASEAN demand is supported by expanding healthcare coverage, medical tourism, urban hospital investment, and improving primary care access in markets such as Indonesia, Thailand, Vietnam, Malaysia, and the Philippines. Traditional wound care products benefit from broad use in surgical recovery, emergency care, occupational injury management, and community health settings, while price sensitivity continues to favor reliable, lower-cost product formats with dependable availability.
The GCC is characterized by modern hospital systems, centralized procurement, medical infrastructure expansion, and growing demand for sterile and premium-quality consumables aligned with international care standards. The European Union prioritizes regulatory compliance, sustainability, tender efficiency, patient safety, and documentation readiness, creating opportunities for suppliers that can prove product consistency, sterility assurance, traceability, and environmentally responsible packaging practices.
BRICS countries combine large patient populations with rising surgical access, diabetes-related wound care needs, trauma burden, and growing domestic manufacturing, making them strategically important for volume demand and localization. G7 markets emphasize quality, traceability, clinical governance, reimbursement scrutiny, and supply continuity, while NATO countries place additional importance on emergency preparedness, military medicine, trauma response, stockpiling, and resilient medical supply chains for essential wound care consumables.
Key Country Insights in Traditional Wound Care
The United States is the largest strategic market for traditional wound care due to high surgical volumes, extensive outpatient care, emergency medicine utilization, home healthcare penetration, and established hospital procurement networks. Canada emphasizes quality, reimbursement discipline, regional health system purchasing, and equitable access across urban and remote care settings, while Mexico benefits from expanding private healthcare, public hospital demand, medical tourism, and proximity to North American supply chains. Brazil is a major Latin American market supported by large hospital networks, public healthcare utilization, trauma care requirements, and a substantial chronic disease burden.
In Europe, the United Kingdom, Germany, France, Italy, and Spain show sustained demand through surgical care, aging populations, pressure injury prevention, and chronic wound management, with Germany standing out for manufacturing strength, hospital efficiency, and rigorous quality expectations. France and the United Kingdom remain shaped by centralized purchasing and clinical governance, while Italy and Spain combine aging demographics with strong public healthcare reliance. Russia maintains demand across hospital, trauma, and emergency care channels, although supply chain reliability, import substitution, and localization are increasingly important considerations.
China and India are central to global growth because of large patient pools, expanding surgical volumes, diabetes-related wound needs, road traffic injuries, and domestic production capabilities. Japan, Australia, and South Korea represent advanced, quality-focused markets where aging demographics, strong clinical standards, infection prevention, and digital health adoption support steady demand for dependable traditional wound care products used in hospitals, long-term care, outpatient clinics, and home-based recovery.
Actionable Recommendations for Industry Leaders
Industry leaders should strengthen product portfolios around core high-volume categories, including sterile gauze, conforming bandages, adhesive tapes, dressing packs, cotton rolls, abdominal pads, and surgical sponges, while differentiating through sterility assurance, packaging convenience, skin-friendly adhesives, absorbency consistency, clear labeling, and supply reliability. Competing only on price increases margin pressure; competing on total value, documentation, clinical usability, and dependable fulfillment improves buyer retention.
Vendors should also invest in regional manufacturing resilience, distributor partnerships, regulatory documentation, and AI-enabled demand forecasting to reduce stockouts and optimize inventory. For healthcare-facing brands, education programs for nurses, caregivers, emergency responders, and home health providers can improve dressing technique, reduce misuse, support infection prevention, and build loyalty in a category where trust, availability, and ease of application are central purchasing drivers.
Research Methodology
This executive summary is built from secondary research, market triangulation, and qualitative interpretation of verified healthcare indicators. The analysis considers public health data from recognized institutions, including global disease burden evidence, diabetes prevalence indicators, surgical care trends, demographic aging statistics, trauma and road injury data, healthcare access indicators, and healthcare infrastructure developments.
The methodology also reviews procurement behavior, regulatory expectations, distribution structures, product adoption patterns, and clinical use cases across hospitals, ambulatory care, retail pharmacies, emergency services, long-term care, and home healthcare. Insights were validated by comparing regional demand drivers, care delivery trends, supply chain dynamics, quality requirements, and competitive positioning across developed and emerging markets, without relying on market sizing, share, or forecasting assumptions.
Conclusion
Traditional wound care remains essential to global healthcare because basic dressings, gauze, bandages, tapes, cotton products, and sponges are used in nearly every care setting. While advanced wound care continues to evolve, traditional products retain durable relevance through affordability, accessibility, clinical familiarity, ease of storage, and compatibility with routine wound cleaning, protection, and dressing changes.
The strongest opportunities will come from suppliers that combine cost-effective manufacturing with quality assurance, sterility, distribution resilience, digital forecasting, and clinician-centered product design. As care delivery expands beyond hospitals, the traditional wound care market will continue to reward organizations that deliver dependable, easy-to-use, compliant, and procurement-ready solutions for surgical recovery, trauma care, chronic wound support, and home-based wound management.
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Definition
- 1.3. Market Segmentation & Coverage
- 1.4. Years Considered for the Study
- 1.5. Currency Considered for the Study
- 1.6. Language Considered for the Study
- 1.7. Key Stakeholders
2. Research Methodology
- 2.1. Introduction
- 2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
- 2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
- 2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
- 2.5. Data Triangulation
- 2.6. Research Outcomes
- 2.7. Research Assumptions
- 2.8. Research Limitations
3. Executive Summary
- 3.1. Introduction
- 3.2. CXO Perspective
- 3.3. Market Size & Growth Trends
- 3.4. Market Share Analysis, 2025
- 3.5. FPNV Positioning Matrix, 2025
- 3.6. New Revenue Opportunities
- 3.7. Next-Generation Business Models
- 3.8. Industry Roadmap
4. Market Overview
- 4.1. Introduction
- 4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
- 4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.1.1. Convert Aging and Chronic Disease Burden into Recurring Care-Continuum Demand
- 4.3.1.2. Follow Wound Care Into Ambulatory and Home Settings With Kit-Based Solutions
- 4.3.1.3. Use Supply Assurance as a Differentiator in a Historically Price-Led Category
- 4.3.1.4. Turn Digital Procurement and Replenishment Into a Demand Multiplier
- 4.3.2. Key Restraints
- 4.3.2.1. Defend Margin Against Commoditization and Private-Label Price Pressure
- 4.3.2.2. Position Traditional Products as Complements to Advanced Wound Care, Not Replacements
- 4.3.3. Key Opportunities
- 4.3.3.1. Scale Recurring Home-Care Kits and Replenishment Programs
- 4.3.3.2. Premiumize Traditional Formats Through Fragile-Skin and Low-Trauma Design
- 4.3.3.3. Win ESG-Sensitive Procurement With Practical Low-Waste Product Design
- 4.3.4. Key Challenges
- 4.3.4.1. Build Tariff-Resilient Sourcing Before Geopolitical Shocks Become Margin Shocks
- 4.3.4.2. Industrialize Compliance to Keep Mature SKUs Commercially Viable
- 4.3.1. Key Drivers
- 4.4. Porter's Five Forces Analysis
- 4.5. PESTLE Analysis
- 4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
- 4.7. Go-to-Market Strategy
5. Market Insights
- 5.1. Consumer Insights & End-User Perspective
- 5.2. Consumer Experience Benchmarking
- 5.3. Opportunity Mapping
- 5.4. Distribution Channel Analysis
- 5.5. Pricing Trend Analysis
- 5.6. Regulatory Compliance & Standards Framework
- 5.7. ESG & Sustainability Analysis
- 5.8. Disruption & Risk Scenarios
- 5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Traditional Wound Care Market, by Product Type
- 7.1. Bandages
- 7.1.1. Cohesive Bandages
- 7.1.2. Compression Bandages
- 7.1.3. Elastic Bandages
- 7.2. Dressings
- 7.2.1. Adhesive Dressings
- 7.2.2. Non Adherent Dressings
- 7.3. Gauze & Sponges
- 7.3.1. Non woven Gauze
- 7.3.2. Woven Gauze
- 7.4. Tapes
- 7.4.1. Cloth Tape
- 7.4.2. Paper Tape
- 7.4.3. Plastic Tape
8. Traditional Wound Care Market, by Wound Type
- 8.1. Acute Wounds
- 8.1.1. Burns
- 8.1.2. Surgical Wounds
- 8.1.3. Traumatic Wounds
- 8.2. Chronic Wounds
- 8.2.1. Arterial Ulcers
- 8.2.2. Diabetic Foot Ulcers
- 8.2.3. Pressure Ulcers
- 8.2.4. Venous Leg Ulcers
9. Traditional Wound Care Market, by Material Type
- 9.1. Natural Materials
- 9.1.1. Cellulose
- 9.1.2. Cotton
- 9.2. Synthetic Materials
- 9.2.1. Polyester
- 9.2.2. Polyurethane
- 9.2.3. Polypropylene
10. Traditional Wound Care Market, by Product Usability
- 10.1. Single Use / Disposable
- 10.2. Reusable
11. Traditional Wound Care Market, by Distribution Channel
- 11.1. Offline
- 11.1.1. Department Stores
- 11.1.2. Direct Sales
- 11.1.3. Specialty Stores
- 11.2. Online
- 11.2.1. Company Websites
- 11.2.2. E-commerce Platforms
12. Traditional Wound Care Market, by End User
- 12.1. Ambulatory Care Centers
- 12.2. Home Care Settings
- 12.3. Hospitals & Clinics
- 12.4. Long-Term Care Facilities
13. Traditional Wound Care Market, by Region
- 13.1. Asia-Pacific
- 13.2. North America
- 13.3. Latin America
- 13.4. Europe
- 13.5. Middle East
- 13.6. Africa
14. Traditional Wound Care Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
15. Traditional Wound Care Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
16. Competitive Landscape
- 16.1. Market Concentration Analysis, 2025
- 16.1.1. Concentration Ratio (CR)
- 16.1.2. Herfindahl Hirschman Index (HHI)
- 16.2. Recent Developments & Impact Analysis, 2025
- 16.3. Product Portfolio Analysis, 2025
- 16.4. Benchmarking Analysis, 2025
17. Company Profiles
- 17.1. Cardinal Health, Inc.
- 17.2. Winner Medical Co., Ltd.
- 17.3. B. Braun SE
- 17.4. PAUL HARTMANN AG
- 17.5. Nitto Denko Corporation
- 17.6. Molnlycke AB
- 17.7. Solventum Corporation
- 17.8. Kenvue Inc.
- 17.9. Gentell
- 17.10. ASO LLC
- 17.11. Lohmann & Rauscher GmbH & Co. KG
- 17.12. Dukal, LLC
- 17.13. Kawamoto Corporation
- 17.14. Hubei Qianjiang Kingphar Medical Material Co., Ltd
- 17.15. Allmed Medical Products Co., Ltd.
- 17.16. Beiersdorf AG
- 17.17. DermaRite Industries, LLC
- 17.18. DeRoyal Industries, Inc.
- 17.19. Dynarex Corporation
- 17.20. Essity AB
- 17.21. Huizhou Foryou Medical Devices Co., Ltd.
- 17.22. Johnson & Johnson Services, Inc.
- 17.23. Osaki Medical Corporation
- 17.24. Ovik Health LLC
- 17.25. Owens & Minor
- 17.26. Reliance Medical Limited
